v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Total revenue $ 178,032 $ 60,281 $ 27,148
Operating expenses:      
Cost of goods sold (70)    
Research and development (149,060) (126,509) (127,726)
Selling, general and administrative (87,261) (73,513) (63,387)
Impairment of long-lived assets (10,401)    
Total operating expenses (246,792) (200,022) (191,113)
Loss from operations (68,760) (139,741) (163,965)
Interest income 6,596 5,964 1,542
Interest expense (3,348)    
Other income (expense), net (1,726) (807) (536)
Loss before income tax expense (67,238) (112,535) (162,959)
Income tax expense (3,576) (1,336) (2,497)
Net loss attributable to ordinary shareholders $ (70,814) $ (113,871) $ (165,456)
Net loss per ordinary share      
Basic net loss per share (in dollars per share) $ (0.05) $ (0.09) $ (0.17)
Diluted net loss per share (in dollars per share) $ (0.05) $ (0.09) $ (0.17)
Weighted average shares outstanding:      
Weighted Average Number of Shares Outstanding, Basic 1,513,810,852 1,206,440,978 967,242,403
Weighted Average Number of Shares Outstanding, Diluted 1,513,810,852 1,206,440,978 967,242,403
Product revenue, net      
Total revenue $ 1,236    
Development revenue      
Total revenue $ 176,796 $ 60,281 $ 27,148

Source